Predict your next investment

Venture Capital
jvencapital.com

See what CB Insights has to offer

Investments

8

Portfolio Exits

2

About jVen Capital

jVEN Capital, LLC is a venture capital and investment management company focused on the Life Sciences. The company is active in the areas of personalized medicine, genetics, medical devices, and specialty therapeutics. The firm was established in 2007 by Evan Jones, an entrepreneur in the molecular diagnostics field. Current investments include OpGen Inc., Signature Genomic Laboratories, LLC, Veracyte Inc, and CAS Medical Systems Inc.

jVen Capital Headquarters Location

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest jVen Capital News

$56M Nantucket listing aims to obliterate record

Jul 9, 2022

jVen Capital’s Evan Jones with 20 Berkeley Avenue (jVen, Compass) Will 500 feet of Nantucket beachfront persuade a buyer to spend $19 million more than anyone ever has for a home there? Venture capitalist Evan Jones and his wife, wildlife photographer Cindy Jones, have listed their estate on the island off Cape Cod for $56 million, the Wall Street Journal reported . According to the brokers, a sale at that price would shatter the previous record for the area, a $37 million sale in April. The estate, at 20 Berkeley Avenue, spans more than 15,000 square feet on Nantucket Harbor, including three structures. The Joneses purchased the three-and-a-half-acre property in 2006 for $16 million, but have since added many features. They custom-built the 11,000-square-foot main house, which has four bedrooms. Highlights include a billiards room, a sauna and several bars. There’s also a relatively new two-bedroom guest house and a four-bedroom guest house more than a century old. Read more The estate has 500 feet of waterfront and 3,000 square feet of patios, porches and decks. The Joneses used the sprawling estate as a vacation home, which is not unusual for even the largest homes on the island. According to the publication, they plan to downsize in Nantucket while spending more time at homes in Jackson Hole and Hawaii. Compass’ Shelly Tretter Lynch and Marybeth Gilmartin-Baugher have the listing . The average home sale price in Nantucket during the first five months of the year was $3.9 million, according to the Compass team. That was an increase from last year as the housing boom has not bypassed the wealthy enclave and its surrounding areas . In April, Boston Red Sox owner John Henry closed on a waterfront property in Nantucket for $25 million. He was expected to close on an adjacent property shortly after; they were marketed together for $42.5 million. The properties combine for 18,000 square feet with 10 bedrooms and 15 bathrooms.

jVen Capital Investments

8 Investments

jVen Capital has made 8 investments. Their latest investment was in Kyverna Therapeutics as part of their Series B on January 1, 2022.

CBI Logo

jVen Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

1/26/2022

Series B

Kyverna Therapeutics

$85M

Yes

11

12/23/2014

Series D - II

Subscribe to see more

$99M

Subscribe to see more

10

5/21/2014

Series D

Subscribe to see more

$99M

Subscribe to see more

10

5/21/2012

Series C

Subscribe to see more

$99M

Subscribe to see more

0

3/12/2012

Growth Equity

Subscribe to see more

$99M

Subscribe to see more

0

Date

1/26/2022

12/23/2014

5/21/2014

5/21/2012

3/12/2012

Round

Series B

Series D - II

Series D

Series C

Growth Equity

Company

Kyverna Therapeutics

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$85M

$99M

$99M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

11

10

10

0

0

jVen Capital Portfolio Exits

2 Portfolio Exits

jVen Capital has 2 portfolio exits. Their latest portfolio exit was Assurex Health on August 04, 2016.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

8/4/2016

Acquired

$99M

1

5/5/2015

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/4/2016

5/5/2015

Exit

Acquired

IPO

Companies

Subscribe to see more

Valuation

$99M

$99M

Acquirer

Subscribe to see more

Sources

1

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.